Altogether, these findings highlight a complex immunoregulatory axis in DLBCL in which the interplay between CCL18, MAPK10, and CD8+ T cells determines whether the microenvironment is predominantly immunosuppressive or retains antitumor capacity. This evidence concerns the gene MAPK10 and diffuse large B-cell lymphoma.